|
|
|
| Changes in TC/HDL, ApoA1 and Lp(a) Levels in Patients with Schizophrenia and Their Relationship with Metabolic Syndrome |
| LU Wen, GONG Chen, XIANG Wen, et al |
| Tianmen First People's Hospital, Hubei Tianmen 431700, China |
|
|
|
|
Abstract Objective: To explore the changes in total cholesterol/high density lipoprotein (TC/HDL), apolipoprotein A1 (ApoA1) and lipoprotein (a) [Lp(a)] and their relationship with metabolic syndrome (MS) in patients with schizophrenia. Methods: A total of 93 patients with schizophrenia in the hospital were selected as the study subjects. General data of patients were counted. The levels of serum TC/HDL, ApoA1 and Lp(a) were detected by enzyme-linked immunosorbent assay, and the patients were divided into MS group (n=32) and non-MS group (n=61) according to whether they were complicated with MS. The general data and levels of serum TC/HDL, ApoA1 and Lp(a) were compared between the two groups. Multivariate Logistic regression analysis was used to analyze the risk factors of MS in patients with schizophrenia. Results: The BMI, SBP, DBP, FPG, serum TG and LDL-C in MS group were significantly higher than those in non-MS group (P<0.05) while the level of HDL-C was significantly lower than that in non-MS group (P<0.05). There were no statistically significant differences in gender, age, course of disease, smoking history, drinking history, antipsychotic drug use, serum TC level, and PANSS score between the two groups (P>0.05). TC/HDL and Lp(a) in MS group were significantly higher than those in non-MS group (P<0.05) while ApoA1 was significantly lower than that in non-MS group (P<0.05). Multivariate Logistic regression analysis showed that BMI, FPG, serum TG, LDL-C, Lp(a) and TC/HDL were risk factors affecting MS in patients with schizophrenia, and serum ApoA1 was a protective factor (P<0.05). Conclusion: Serum TC/HDL, ApoA1 and Lp (a) levels are the influencing factors of MS in patients with schizophrenia, and the increases of TC/HDL and Lp (a) and the decrease of ApoA1 can increase the risk of MS in patients.
|
|
|
|
|
|
[1] 许宏,周勇杰,曾玲芸,等.慢性精神分裂症患者代谢综合征发生率及代谢指标的性别差异研究[J].中国神经精神疾病杂志,2021,47(11):656-660.
[2] 李友凤,王春慧,孙文先,等.总胆固醇/高密度脂蛋白胆固醇比值对脑卒中复发的预测价值[J].中国实用神经疾病杂志,2020,23(9):771-775.
[3] 王汉,李儒琳.血清血小板活化因子、脂蛋白(a)、纤维蛋白单体对骨折患者发生近端深静脉血栓评估价值[J].创伤与急危重病医学,2021,9(2):120-123.
[4] Ijaz S,Bolea B,Davies S,et al.Antipsychotic polypharmacy and metabolic syndrome in schizophrenia:a review of systematic reviews[J].BMC Psychiatry,2018,18(1):275.
[5] 陈思源,李娇娇,张健煜,等.总胆固醇/高密度脂蛋白胆固醇比值与无症状颈动脉粥样硬化斑块稳定性的相关性[J].国际脑血管病杂志,2021,29(11):820-824.
[6] 付琳,王敏,李瑾.冠心病病人载脂蛋白B/载脂蛋白A1、胱抑素C、血清胆红素水平变化及其与冠状动脉病变严重程度的相关性[J].中西医结合心脑血管病杂志,2022,20(7):1287-1292.
[7] 北京心脏学会.脂蛋白(a)与心血管疾病风险关系及临床管理的专家科学建议[J].中国循环杂志,2021,36(12):1158-1167.
[8] 邓以川,李川,颜小杭,等.CT血管成像技术评估血液因子在冠状动脉硬化狭窄的相关性研究[J].实用放射学杂志,2021,37(4):567-570,602.
[9] 熊敏,赖繁,葛会生,等.血清D-二聚体、脂蛋白a与妊娠期代谢综合征的相关性研究[J].临床和实验医学杂志,2021,20(18):1987-1990. |
|
|
|
2023, Vol. 29 
